Nathan Rice
Stock Analyst at Piper Sandler
(2.88)
# 1,552
Out of 5,127 analysts
60
Total ratings
50%
Success rate
8.57%
Average return
Main Sectors:
Stocks Rated by Nathan Rice
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FMBH First Mid Bancshares | Maintains: Overweight | $49 → $48 | $40.10 | +19.72% | 5 | Nov 3, 2025 | |
| MBIN Merchants Bancorp | Maintains: Overweight | $41 → $42 | $35.85 | +17.15% | 9 | Oct 30, 2025 | |
| BY Byline Bancorp | Maintains: Overweight | $34 → $35 | $30.35 | +15.32% | 9 | Oct 28, 2025 | |
| BFC Bank First | Maintains: Neutral | $137 → $142 | $125.44 | +13.20% | 9 | Oct 23, 2025 | |
| CVS CVS Health | Maintains: Buy | $85 → $74 | $80.60 | -8.19% | 2 | May 2, 2024 | |
| NIC Nicolet Bankshares | Assumes: Neutral | $84 | $127.30 | -34.01% | 1 | Jan 10, 2024 | |
| ALGN Align Technology | Downgrades: Sell | $197 | $170.58 | +15.49% | 10 | Dec 11, 2023 | |
| ELAN Elanco Animal Health | Maintains: Sell | $11 → $9 | $23.24 | -61.27% | 1 | Apr 25, 2023 | |
| IDXX IDEXX Laboratories | Upgrades: Buy | $530 → $435 | $712.39 | -38.94% | 4 | Jul 21, 2022 | |
| CI The Cigna Group | Initiates: Neutral | $233 | $283.91 | -17.93% | 5 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $83 | $46.92 | +76.90% | 4 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $20.27 | -26.00% | 1 | Dec 19, 2019 |
First Mid Bancshares
Nov 3, 2025
Maintains: Overweight
Price Target: $49 → $48
Current: $40.10
Upside: +19.72%
Merchants Bancorp
Oct 30, 2025
Maintains: Overweight
Price Target: $41 → $42
Current: $35.85
Upside: +17.15%
Byline Bancorp
Oct 28, 2025
Maintains: Overweight
Price Target: $34 → $35
Current: $30.35
Upside: +15.32%
Bank First
Oct 23, 2025
Maintains: Neutral
Price Target: $137 → $142
Current: $125.44
Upside: +13.20%
CVS Health
May 2, 2024
Maintains: Buy
Price Target: $85 → $74
Current: $80.60
Upside: -8.19%
Nicolet Bankshares
Jan 10, 2024
Assumes: Neutral
Price Target: $84
Current: $127.30
Upside: -34.01%
Align Technology
Dec 11, 2023
Downgrades: Sell
Price Target: $197
Current: $170.58
Upside: +15.49%
Elanco Animal Health
Apr 25, 2023
Maintains: Sell
Price Target: $11 → $9
Current: $23.24
Upside: -61.27%
IDEXX Laboratories
Jul 21, 2022
Upgrades: Buy
Price Target: $530 → $435
Current: $712.39
Upside: -38.94%
The Cigna Group
Dec 14, 2021
Initiates: Neutral
Price Target: $233
Current: $283.91
Upside: -17.93%
Dec 14, 2021
Initiates: Neutral
Price Target: $83
Current: $46.92
Upside: +76.90%
Dec 19, 2019
Initiates: Overweight
Price Target: $15
Current: $20.27
Upside: -26.00%